Clinical Trial Update: SFX-01 in the Treatment and Evaluation of Metastatic Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for SFX-01 in metastatic breast cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Neoplasm

Drugs mentioned

• SFX-01

Snippet

Sponsor: Evgen Pharma | Conditions: Breast Neoplasm | Phase 2 | Status: COMPLETED